12:00 AM
Mar 26, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

SecreFlo regulatory update

FDA's Gastrointestinal Drugs Advisory Committee will meet on May 31 to discuss an NDA from Repligen for SecreFlo to improve detection...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >